|
Status |
Public on Apr 07, 2021 |
Title |
Low-dose DNA demethylating therapy induces reprogramming of diverse cancer-related pathways at the single-cell level |
Organism |
Homo sapiens |
Experiment type |
Methylation profiling by genome tiling array Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
32958049 |
|
Submission date |
Apr 07, 2021 |
Last update date |
Jul 12, 2021 |
Contact name |
Hideyuki Takeshima |
E-mail(s) |
takeshima.hideyuki@hoshi.ac.jp
|
Organization name |
Hoshi University
|
Department |
Institute for Advanced Life Sciences
|
Lab |
Department of Epigenomics
|
Street address |
2-4-41 Ebara
|
City |
Shinagawa-ku |
State/province |
Tokyo |
ZIP/Postal code |
142-8501 |
Country |
Japan |
|
|
Platforms (2) |
GPL13534 |
Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
Samples (13)
|
GSM4494968 |
DNA methylation in mock-treated bulk HCT116 cells |
GSM4494969 |
DNA methylation in decitabine-treated bulk HCT116 cells |
GSM4494970 |
DNA methylation in clone H3-01 |
|
This SuperSeries is composed of the following SubSeries: |
GSE149255 |
DNA methylation analysis of cloned HCT116 cells treated with a DNA demethylating drug. |
GSE171429 |
scRNA-seq of DAC-treated and mock-treated HCT116. |
|
Relations |
BioProject |
PRJNA720322 |